Our Mission

The National Lung Cancer Roundtable (NLCRT) is a consortium of public, private, and voluntary organizations that work together to fight lung cancer by engaging in the research and projects that no one organization can take on alone. It is the NLCRT’s belief that working collectively will drive progress faster than working alone.

Founded in early 2017, the NLCRT is guided by its strategic plan with direction and input from an active multi-disciplinary Steering Committee. Task Groups develop and manage projects that fall into their scope of work along the lung cancer continuum. This work aims to promote increased lung cancer awareness, risk reduction, early detection, and assures optimal diagnosis and therapy through educating patients, their families, and providers, supporting targeted clinical and policy-related research, and ending the stigma and nihilism associated with a diagnosis of lung cancer.

The Roundtable serves as a catalyst to stimulate greater levels of collaborative engagement among member organizations’ work on key lung cancer issues. It does not duplicate the efforts of any of its members, rather we engage in dialogue with them to find the gaps in our knowledge of issues around lung cancer. These complex challenges require the complex solutions that can only come from multi-disciplinary collaborations. Together we can make the most effective progress in fighting the disease.

Our Members

A fundamental premise of the Roundtable is that collective action among the member organizations will be more successful in reducing the burden of disease, and reducing that burden faster. A core principle of the Roundtable is that it will not duplicate or take on roles of member organizations; rather, the Roundtable seeks to enhance organizations’ contributions to lung cancer control through greater engagement with other key organizations, as well as to take on initiatives that all organizations would judge to be worthy, but would be unlikely to initiate on their own.

Together, members work to share information, identify needs and opportunities, and address gaps in research, programs, activities, and services relating to lung cancer. The strength of such a partnership, united in mission, enhances the work of each member and furthers the cause of lung cancer prevention early detection, and control. 

Member organization recruitment began in mid-2017 and more than 140 organizations have officially become members. The inaugural  NLCRT Annual meeting was held in Washington DC, in December 2017.

Become a Member

It takes many voices to create an effective coalition. Learn how your organization can apply to become a member of the Roundtable.


Ella A. Kazerooni, MD, MS

Chair of the National Lung Cancer Roundtable

Douglas E. Wood, MD

Vice Chair of the National Lung Cancer Roundtable

Robert A. Smith, PhD

Principal Investigator of the National Lung Cancer Roundtable